» Articles » PMID: 11128471

Taenia Solium: Molecular Cloning and Serologic Evaluation of 14- and 18-kDa Related, Diagnostic Antigens

Overview
Journal J Parasitol
Specialty Parasitology
Date 2000 Dec 29
PMID 11128471
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We are attempting to design a simpler assay based on synthetic or recombinant antigens to replace the labor-intensive enzyme-linked immunoelectrotransfer blot (EITB-C), which is currently used to diagnose Taenia solium cysticercosis. From the lentil lectin-bound fraction of cyst glycoproteins (the LLGP fraction used in the EITB-C), we previously identified and purified 2 related polypeptides of 14- and 18-kDa that demonstrated diagnostic usefulness. Using degenerate oligonucleotide primers corresponding to amino acid sequences of these polypeptides and a cDNA library prepared from T. solium cysticerci, we amplified cDNA clones that represent the 14- and 18-kDa polypeptides. These clones share sequence homology at the nucleotide and amino acid levels. Synthetic polypeptides that represented the full-length, mature proteins (sTS14 and sTS18) were assessed for serologic potential using an ELISA. sTS14, but not sTS18, demonstrated utility as a diagnostic antigen. sTS14 was recognized by antibodies in a majority of the sera from patients with cysticercosis and none of the sera from persons with other helminth infections or uninfected human sera. Furthermore, polyclonal antibodies to sTS14 reacted with 6 discrete proteins present in the LLGP cyst fraction, suggesting that TS14 is a subunit of other previously described antigens used for diagnosing cysticercosis.

Citing Articles

From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis.

Toribio L, Bustos J, Garcia H Front Parasitol. 2025; 3():1394089.

PMID: 39817165 PMC: 11732113. DOI: 10.3389/fpara.2024.1394089.


Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis Cure.

Tang N, Nash T, Corda M, Nutman T, OConnell E Emerg Infect Dis. 2023; 29(7):1340-1348.

PMID: 37347506 PMC: 10310364. DOI: 10.3201/eid2907.230364.


Psychiatric Disorders of Neurocysticercosis: Narrative Review.

El-Kady A, Allemailem K, Almatroudi A, Abler B, Elsayed M Neuropsychiatr Dis Treat. 2021; 17:1599-1610.

PMID: 34079258 PMC: 8164720. DOI: 10.2147/NDT.S306585.


A gel-free proteomic analysis of Taenia solium and Taenia crassiceps cysticerci vesicular extracts.

Verissimo da Costa G, Peralta R, Kalume D, Alves A, Peralta J Parasitol Res. 2018; 117(12):3781-3790.

PMID: 30215138 DOI: 10.1007/s00436-018-6080-7.


Present status of laboratory diagnosis of human taeniosis/cysticercosis in Europe.

Gomez-Morales M, Garate T, Blocher J, Devleesschauwer B, Smit G, Schmidt V Eur J Clin Microbiol Infect Dis. 2017; 36(11):2029-2040.

PMID: 28669015 PMC: 5653711. DOI: 10.1007/s10096-017-3029-1.